Gewählte Publikation:
SHR
Neuro
Krebs
Kardio
Lipid
Stoffw
Microb
Kuret, T; Burja, B; Feichtinger, J; Thallinger, GG; Frank-Bertoncelj, M; Lakota, K; Žigon, P; Sodin-Semrl, S; Čučnik, S; Tomšič, M; Hočevar, A.
Gene and miRNA expression in giant cell arteritis-a concise systematic review of significantly modified studies.
Clin Rheumatol. 2019; 38(2):307-316
Doi: 10.1007/s10067-018-4231-y
Web of Science
PubMed
FullText
FullText_MUG
- Co-Autor*innen der Med Uni Graz
-
Feichtinger Julia
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
-
Giant cell arteritis (GCA) is a systemic vasculitis in individuals older than 50 years, characterized by headaches, visual disturbances, painful scalp, jaw claudication, impairment of limb arteries, and systemic inflammation, among other symptoms. GCA diagnosis is confirmed by a positive temporal artery biopsy (TAB) or by imaging modalities. A prominent acute phase response with inflammation is the hallmark of the disease, predominantly targeting large- and medium-sized arteries leading to stenosis or occlusion of arterial lumen. To date, there are no reliable tissue markers specific for GCA. Scarce reports have indicated the importance of epigenetics in GCA. The current systematic review reports significantly changed candidate biomarkers in TABs of GCA patients compared to non-GCA patients using qPCR.
- Find related publications in this database (Keywords)
-
Giant cell arteritis
-
Temporal artery biopsy
-
Vasculitis
-
miRNA
-
mRNA expression